DK1146897T3 - Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle - Google Patents

Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Info

Publication number
DK1146897T3
DK1146897T3 DK00906234T DK00906234T DK1146897T3 DK 1146897 T3 DK1146897 T3 DK 1146897T3 DK 00906234 T DK00906234 T DK 00906234T DK 00906234 T DK00906234 T DK 00906234T DK 1146897 T3 DK1146897 T3 DK 1146897T3
Authority
DK
Denmark
Prior art keywords
mia
cartilage
activity factor
inhibitory activity
bone repair
Prior art date
Application number
DK00906234T
Other languages
English (en)
Inventor
Carola Dony
Gabriele Proetzel
Ulrike Leser-Reiff
Original Assignee
Carola Dony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carola Dony filed Critical Carola Dony
Application granted granted Critical
Publication of DK1146897T3 publication Critical patent/DK1146897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00906234T 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle DK1146897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101315A EP1025871A1 (en) 1999-01-28 1999-01-28 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
PCT/EP2000/000623 WO2000044401A1 (en) 1999-01-28 2000-01-27 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair

Publications (1)

Publication Number Publication Date
DK1146897T3 true DK1146897T3 (da) 2003-02-03

Family

ID=8237403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906234T DK1146897T3 (da) 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Country Status (11)

Country Link
US (1) US6890897B1 (da)
EP (2) EP1025871A1 (da)
JP (2) JP4800483B2 (da)
AT (1) ATE224731T1 (da)
AU (1) AU765929B2 (da)
CA (1) CA2361238C (da)
DE (1) DE60000501T2 (da)
DK (1) DK1146897T3 (da)
ES (1) ES2180514T3 (da)
PT (1) PT1146897E (da)
WO (1) WO2000044401A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7494664B2 (en) * 2001-10-25 2009-02-24 Japan Science And Technology Agency Composite biomaterials
WO2003066083A1 (en) * 2002-02-04 2003-08-14 Sumitomo Pharmaceuticals Company, Limited Preparations for treating bone fracture or bone loss or elevating bone density
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2007061889A2 (en) 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
CA2656278C (en) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US7671014B2 (en) 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
KR101333279B1 (ko) * 2006-10-06 2013-11-27 에스씨아이엘 테크놀로지 게엠베하 약학적 응용을 위한 건조된 재구성 소포 형성
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
ES2422259T3 (es) 2008-02-07 2013-09-10 Biomimetic Therapeutics Inc Composiciones para la osteogénesis por distracción
US9616153B2 (en) 2008-04-17 2017-04-11 Warsaw Orthopedic, Inc. Rigid bone graft substitute
KR20110067035A (ko) 2008-09-09 2011-06-20 바이오미메틱 세라퓨틱스, 인크. 건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
CN107080834A (zh) 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
RU2588658C2 (ru) 2010-04-27 2016-07-10 ЭсСиАйЭл Текнолоджи ГмбХ Стабильные водные композиции белка mia/cd-rap
WO2018129470A1 (en) * 2017-01-09 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Reversing deficient hedgehog signaling restores deficient skeletal regeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
EP0513334A4 (en) * 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
EP0710248B1 (de) * 1993-07-20 1999-09-29 Roche Diagnostics GmbH Melanom-inhibierendes protein
TW369414B (en) * 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JPH10194987A (ja) * 1997-01-14 1998-07-28 Youtai Iwamoto 骨・軟骨形成用組成物
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
EP1025871A1 (en) 2000-08-09
AU765929B2 (en) 2003-10-02
EP1146897A1 (en) 2001-10-24
EP1146897B1 (en) 2002-09-25
JP2011084574A (ja) 2011-04-28
DE60000501D1 (de) 2002-10-31
AU2799000A (en) 2000-08-18
CA2361238A1 (en) 2000-08-03
WO2000044401A1 (en) 2000-08-03
PT1146897E (pt) 2003-02-28
US6890897B1 (en) 2005-05-10
DE60000501T2 (de) 2003-02-13
JP4800483B2 (ja) 2011-10-26
CA2361238C (en) 2010-08-10
ES2180514T3 (es) 2003-02-16
ATE224731T1 (de) 2002-10-15
JP2002537229A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
DE69602624D1 (de) Instrumentation zur Verwendung in der orthopädischen Chirurgie
ES2180514T3 (es) Uso de un factor con actividad inhibidora del melanoma (mia) para reparacion de cartilagos y huesos.
NO962304L (no) BMP-12, BMP-13 og sene-induserende sammensetninger derav
DE60006356D1 (de) Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DE69528058D1 (de) Bmp-9 zusammensetzungen
DE60020526D1 (de) Osteogene pastenzusammensetzungen und ihre verwendung
DE59706273D1 (de) Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
ATE162223T1 (de) Osteoinduktive zusammensetzungen
DE59711081D1 (de) Marknagelsystem zur frakturheilung bzw. knochenverlängerung
DE69720177D1 (de) Markraumnagel für die Versorgung von Frakturen der Hüfte
DK1690874T3 (da) BMP-12, BMP-13 og sene-inducerende sammensætninger deraf
ATE371650T1 (de) Cycloalkyl-derivate als inhibitoren der knochenresorption und vitronectinrezeptor- antagonisten
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
NO973400D0 (no) Nye aminoderivater som inhibitorer av benresorpsjon og vitronektinreseptorantagonister
DE60213800D1 (de) Nagel und Schraube für chirurgisches Fixationssystem
NO20005928L (no) Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon
ATE392869T1 (de) Artikulierbares implantatsystem
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
EP1095159A4 (en) Bone Morphogenetic Protein
DE60221804D1 (de) Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
ATE277902T1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
EP1150684A4 (en) BONE CEMENT ANTI-RESORPTION AND ALLOGENOUS BONE IMPLANTS, AUTOGRAFTS AND XENOGRAFTS
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DK1027086T3 (da) Formede legemer til anvendelse som implantater i humanmedicin og metode til fremstilling af sådanne formede legemer